|
HS Code |
494586 |
As an accredited 4-Bromo-2-Iodobenzoic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-2-Iodobenzoic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over years in the lab, chemists like me have learned the advantage of turning to compounds that feature both bromine and iodine substituents. 4-Bromo-2-Iodobenzoic Acid is one of those standout reagents. Drawing from real bench experience, this product, with its aromatic benzoic acid core and both halogens on the ring, opens up synthetic flexibility that’s tough to match. Its molecular formula, C7H4BrIO2, offers a combination that works wonders in late-stage coupling reactions and special applications for both researchers and commercial process chemists looking for something beyond the ordinary halogenated benzoic acids.
Handling 4-Bromo-2-Iodobenzoic Acid, you get a solid, usually appearing as an off-white to pale yellow powder, which points to its purity. The molecular weight sits at 338.92 g/mol, and the melting point hangs in the 180-186°C range if handled correctly, making it convenient for standard storage and use without the thermal instability that sometimes complicates working with other iodinated compounds. As someone who’s run plenty of Suzuki-Miyaura couplings, I can vouch for its sharp solubility in DMSO and moderate solubility in DMF and acetonitrile, while water solubility stays predictably low—just as expected for heavily halogenated aromatics.
For anyone moving beyond bench scale, chemical consistency matters. Analytical techniques like NMR, HPLC, and elemental analysis tend to report high assay values for this compound, and infrared analysis confirms the solid’s carboxylic acid and halogen substituents by their fingerprint peaks. Purity above 98% is what you’ll see from reputable suppliers, and I always advise double-checking with in-house spectra rather than relying on a piece of paper.
What makes 4-Bromo-2-Iodobenzoic Acid stand out isn’t just structural novelty; the dual-halogen design lets organic chemists select which halogen to displace in a controlled sequence. In cross-coupling, the iodide leaves more readily than the bromide, and that subtle difference is why so many modern synthetic routes choose this molecule when building up complex pharmacophores or constructing multi-substituted aromatic frameworks.
Back when I started out, the go-to benzoic acids were mono-halogenated: you’d pick either a bromo- or iodo-substitution, run your reaction, and hope for the best. As medicinal chemistry projects grew more demanding, I started to appreciate the flexibility in 4-Bromo-2-Iodobenzoic Acid. Its use in sequential coupling—removing the iodine first, then the bromine—meant not only more precise product design but also less time spent on protection-and-deprotection gymnastics. That saves budget, solvents, and unnecessary tweaking.
Researchers working in the agrochemical, materials science, and especially pharmaceutical sectors value this acid most for its ability to facilitate stepwise diversification. Late-stage modifications on the benzoate scaffold often call for such versatility. The results? Fewer synthetic dead ends, more hit compounds, and clearer SAR results in bioassays.
Often, newcomers ask why anyone would use a dihalogenated acid like this one instead of sticking to the more familiar 4-bromobenzoic or 2-iodobenzoic acid. The answer comes down to selectivity and synthetic design. In practice, you’ll find many transformations—Suzuki, Sonogashira, Heck—benefit from the opportunity to swap out only the more labile halogen. The iodine almost always reacts first under palladium catalysis, so you can design two-stage schemes on a single aromatic core, sparing yourself awkward protecting group strategies.
With mono-halogenated acids, the scope stays limited to a single transformation. You can carry out only one coupling before the aromatic core loses its reactive handle. By contrast, 4-Bromo-2-Iodobenzoic Acid gives you built-in orthogonality. You get to decide exactly how and when to turn each handle into a new substituent, which expands both creativity and efficiency in synthesis.
On top of reactivity, the physical stability and storage profile makes it easier than alternatives packed with nitro or amino groups, which sometimes degrade or lose integrity under standard conditions. Anyone stocking a research synthesis lab appreciates the fact that you don’t need excessive care or inert atmosphere for short-term benchwork.
Traditional syntheses often push chemists into picking mono-substituted partners, which means plenty of time spent building up scaffolds only to tear them down for the next transformation. I’ve seen groups lose valuable project weeks re-engineering routes that could have started smarter with dual-halogen aromatics like this one.
Many academic and industry teams have struggled to maintain throughput when every new analog means building a new aryl source from scratch. By choosing multi-substituted acids—especially those with differentiated leaving groups—chemists free up time and resources. Intermediate complexity increases, but so do the unique opportunities for diversity. In pharmaceutical discovery, being able to systematically append different fragments at C-2 and C-4 while keeping the carboxylic acid in place remains a rare and powerful advantage.
The environmental impact of halogenated intermediates sometimes draws concern, especially from compliance departments and safety officers. As with all such chemicals, responsible handling, closed systems, and robust waste management plans keep things safe and sustainable. Benchtop work with 4-Bromo-2-Iodobenzoic Acid typically doesn’t generate unusual hazards, though I’d recommend good ventilation and gloves as standard lab practice. As regulations evolve, the potential to develop greener halogenation and coupling methods will only raise the appeal of flexible platforms like this one.
Ask any practicing organic chemist about their frustrations, and you’ll hear a familiar refrain: bottlenecks, low-yielding steps, and wasted starting material. 4-Bromo-2-Iodobenzoic Acid helps sidestep those issues through clever use of orthogonal reactivity. With over twenty years of experience supporting both medicinal development teams and manufacturing chemists, I’ve seen these “building block” acids cut down on the trial-and-error approach and speed the route optimization process.
Besides direct use in synthesis, this compound finds a role in material science applications requiring tailored functionalization. Polymers and sensors based on aromatic carboxylic acids benefit from the dual-point functionalization. By switching out only one halogen at a time, designers can tune the electronic properties or introduce binding motifs with fewer synthetic cycles. That precision stands out compared to the shotgun approach required by simple mono-halogen analogs.
In the world of drug discovery, speed equals competitiveness. Using advanced intermediates like 4-Bromo-2-Iodobenzoic Acid makes it easier to chase new structural classes without starting from zero every time. Smaller, leaner teams make faster progress today than ever before, and the versatility of reagents like this one keeps them one step ahead.
Any seasoned scientist knows that purity, batch-to-batch consistency, and full characterization are the hallmarks of a reliable starting material. Over my career, I’ve rejected plenty of batches with off-target decomposition products, especially among more sensitive aryl iodides. Reputable sources for 4-Bromo-2-Iodobenzoic Acid provide reagent grades that withstand rigorous analysis, and careful management of storage conditions preserves shelf life.
Best practice advice: re-test each new lot before committing to a full scale-up. A quick proton NMR and HPLC run can catch issues like residual solvents or halogen-exchange byproducts. It’s rarely worth risking the whole sequence on a questionable lot, no matter how reassuring the paperwork might look. Treat this compound like any other complex intermediate: pay attention, keep detailed records, and verify every critical parameter before using at scale.
Large pharma groups usually rely on automated tracking of purity and stability during high-throughput synthesis. Smaller teams can achieve the same with disciplined workflow and a little extra vigilance. Having a stock bottle you trust cuts down on troubleshooting headaches, especially when tight project timelines demand reliability at every step.
Traditional 4-bromobenzoic acid offers only mild reactivity, making it suitable for slow, controlled couplings. 2-iodobenzoic acid, on the other hand, reacts more rapidly but lacks the additional handle for further elaboration. Dual-substituted 4-Bromo-2-Iodobenzoic Acid gives you both—a fast-reacting iodine and a modifiable bromide, so you can access two divergent synthetic routes from one starting point.
During method development, you’ll find it easier to tailor conditions for selectivity. For instance, using milder palladium sources or base selection, you can target only the C-2 iodine for displacement and save the C-4 bromide for a separate transformation. This staged approach outperforms the single-action coupling you get from mono-halogenated benzoic acids.
Efforts to expand cross-coupling methodology—a major theme in modern organic chemistry—use these dual-halogen systems as case studies for robustness and selectivity. Teams focusing on heterocycle formation, peptide modification, and macrocycle construction regularly report higher yields, fewer side reactions, and streamlined purifications compared to early-stage, mono-functionalized routes.
Having faced multi-week synthetic hurdles with limited substrate choices, I’ll never downplay the relief when a reagent like 4-Bromo-2-Iodobenzoic Acid cuts cycles from a project timeline. These cases aren’t rare in the fast-moving world of real-world medicinal chemistry. The cost might be marginally higher per gram than simpler acids, but the return in researcher time and successful deliverables far outweighs the investment. No more tearing down the scaffold between couplings just to rebuild for the next analog.
In the hands of a smart chemist, this compound speeds up SAR campaigns and makes structure optimization cycles feasible even with a small team. Teams that build out chemical space fast get more chances to find leads, and, from my experience, reduced repetition and higher quality data come with it.
For small businesses or startups aiming to bring new life to their chemistry programs, adding 4-Bromo-2-Iodobenzoic Acid to the lineup can bring a step change. It unlocks routes that deliver higher diversity in fewer steps, meaning every research dollar goes further.
Green chemistry principles keep rising to the top for teams balancing performance and environmental cost. 4-Bromo-2-Iodobenzoic Acid, by facilitating stage-specific couplings and reducing the need for extensive protecting group strategies, helps cut down on waste and excess solvent use. Trends in catalysis—nickel as a complement to palladium, less toxic ligands, milder conditions—fit well with dual-halogen substrates, so future improvements in sustainability will likely start from such building blocks.
Anecdotally, as a supporter of waste-minimization in the lab, I’ve seen the benefit when one intermediate fits multiple routes. There’s less temptation to over-order, throw away off-target fractions, or run endless protection-deprotection cycles. The experiences of major pharma groups show that the key to greener chemistry isn’t radical overhauls but smart choices at the intermediate level.
Chemical development never stands still, and demands for advanced intermediates will grow sharper as new drug targets and material challenges emerge. To keep ahead, teams need adaptable platforms that grow with the science. 4-Bromo-2-Iodobenzoic Acid checks several boxes for the future: built-in orthogonality, reliability, and straightforward structure-activity exploration.
From what I’ve seen across pharma, agrochemical, and polymer research settings, product success starts with reagents that solve real workflow issues. Every chemist tasked with designing new heterocycles, preparing tagged probes, or linking bioconjugates knows the pain of restrictive starting materials. With this dual-halogen benzoic acid, that limitation fades, replaced by creative options and a smoother journey from idea to final compound.
Progress depends on embracing high-function intermediates and matching product design with advanced synthetic needs. Rather than fighting with inflexible molecules or spending days re-inventing established transformations, a smart, targeted choice in starting material shifts the odds toward success.
Looking back at two decades in chemical synthesis, the reagents that earn my respect are not the flashiest but those that solve actual problems and give teams real control over outcome. 4-Bromo-2-Iodobenzoic Acid has shown me—and countless colleagues—that thoughtful molecular construction matters. Its unique combination of halogen handles, stability, and ease of use raise the bar for research and industrial chemistry alike. As discovery keeps pushing us into more complex frontiers, picking the right intermediates—ones that boost productivity, open up creative pathways, and lessen the burden on both people and planet—will lead the field. This compound does just that, and I expect it will stay a mainstay for those seeking smart solutions to hard synthetic problems.